Cargando…

Interval post-colonoscopy colorectal cancer following a negative colonoscopy in a fecal immunochemical test-based screening program

Background  In the Dutch colorectal (CRC) screening program, fecal immunochemical test (FIT)-positive individuals are referred for colonoscopy. If no relevant findings are detected at colonoscopy, individuals are reinvited for FIT screening after 10 years. We aimed to assess CRC risk after a negativ...

Descripción completa

Detalles Bibliográficos
Autores principales: van de Schootbrugge-Vandermeer, Hilliene J., Kooyker, Arthur I., Wisse, Pieter H. A., Nagtegaal, Iris D., Geuzinge, Hiltje A., Toes-Zoutendijk, Esther, de Jonge, Lucie, Breekveldt, Emilie C. H., van Vuuren, Anneke J., van Kemenade, Folkert J., Ramakers, Christian R. B., Dekker, Evelien, Lansdorp-Vogelaar, Iris, Spaander, Manon C. W., van Leerdam, Monique E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684335/
https://www.ncbi.nlm.nih.gov/pubmed/37793423
http://dx.doi.org/10.1055/a-2136-6564
_version_ 1785151380417150976
author van de Schootbrugge-Vandermeer, Hilliene J.
Kooyker, Arthur I.
Wisse, Pieter H. A.
Nagtegaal, Iris D.
Geuzinge, Hiltje A.
Toes-Zoutendijk, Esther
de Jonge, Lucie
Breekveldt, Emilie C. H.
van Vuuren, Anneke J.
van Kemenade, Folkert J.
Ramakers, Christian R. B.
Dekker, Evelien
Lansdorp-Vogelaar, Iris
Spaander, Manon C. W.
van Leerdam, Monique E.
author_facet van de Schootbrugge-Vandermeer, Hilliene J.
Kooyker, Arthur I.
Wisse, Pieter H. A.
Nagtegaal, Iris D.
Geuzinge, Hiltje A.
Toes-Zoutendijk, Esther
de Jonge, Lucie
Breekveldt, Emilie C. H.
van Vuuren, Anneke J.
van Kemenade, Folkert J.
Ramakers, Christian R. B.
Dekker, Evelien
Lansdorp-Vogelaar, Iris
Spaander, Manon C. W.
van Leerdam, Monique E.
author_sort van de Schootbrugge-Vandermeer, Hilliene J.
collection PubMed
description Background  In the Dutch colorectal (CRC) screening program, fecal immunochemical test (FIT)-positive individuals are referred for colonoscopy. If no relevant findings are detected at colonoscopy, individuals are reinvited for FIT screening after 10 years. We aimed to assess CRC risk after a negative colonoscopy in FIT-positive individuals. Methods  In this cross-sectional cohort study, data were extracted from the Dutch national screening information system. Participants with a positive FIT followed by a negative colonoscopy between 2014 and 2018 were included. A negative colonoscopy was defined as a colonoscopy during which no more than one nonvillous, nonproximal adenoma < 10 mm or serrated polyp < 10 mm was found. The main outcome was interval post-colonoscopy CRC (iPCCRC) risk. iPCCRC risk was reviewed against the risk of interval CRC after a negative FIT (FIT IC) with a 2-year screening interval. Results  35 052 FIT-positive participants had a negative colonoscopy and 24 iPCCRCs were diagnosed, resulting in an iPCCRC risk of 6.85 (95 %CI 4.60–10.19) per 10 000 individuals after a median follow-up of 1.4 years. After 2.5 years of follow-up, age-adjusted iPCCRC risk was approximately equal to FIT IC risk at 2 years. Conclusion  Risk of iPCCRC within a FIT-based CRC screening program was low during the first years after colonos-copy but, after 2.5 years, was the same as the risk in FIT-negative individuals at 2 years, when they are reinvited for screening. Colonoscopy quality may therefore require further improvement and FIT screening interval may need to be reduced after negative colonoscopy.
format Online
Article
Text
id pubmed-10684335
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Georg Thieme Verlag KG
record_format MEDLINE/PubMed
spelling pubmed-106843352023-11-30 Interval post-colonoscopy colorectal cancer following a negative colonoscopy in a fecal immunochemical test-based screening program van de Schootbrugge-Vandermeer, Hilliene J. Kooyker, Arthur I. Wisse, Pieter H. A. Nagtegaal, Iris D. Geuzinge, Hiltje A. Toes-Zoutendijk, Esther de Jonge, Lucie Breekveldt, Emilie C. H. van Vuuren, Anneke J. van Kemenade, Folkert J. Ramakers, Christian R. B. Dekker, Evelien Lansdorp-Vogelaar, Iris Spaander, Manon C. W. van Leerdam, Monique E. Endoscopy Background  In the Dutch colorectal (CRC) screening program, fecal immunochemical test (FIT)-positive individuals are referred for colonoscopy. If no relevant findings are detected at colonoscopy, individuals are reinvited for FIT screening after 10 years. We aimed to assess CRC risk after a negative colonoscopy in FIT-positive individuals. Methods  In this cross-sectional cohort study, data were extracted from the Dutch national screening information system. Participants with a positive FIT followed by a negative colonoscopy between 2014 and 2018 were included. A negative colonoscopy was defined as a colonoscopy during which no more than one nonvillous, nonproximal adenoma < 10 mm or serrated polyp < 10 mm was found. The main outcome was interval post-colonoscopy CRC (iPCCRC) risk. iPCCRC risk was reviewed against the risk of interval CRC after a negative FIT (FIT IC) with a 2-year screening interval. Results  35 052 FIT-positive participants had a negative colonoscopy and 24 iPCCRCs were diagnosed, resulting in an iPCCRC risk of 6.85 (95 %CI 4.60–10.19) per 10 000 individuals after a median follow-up of 1.4 years. After 2.5 years of follow-up, age-adjusted iPCCRC risk was approximately equal to FIT IC risk at 2 years. Conclusion  Risk of iPCCRC within a FIT-based CRC screening program was low during the first years after colonos-copy but, after 2.5 years, was the same as the risk in FIT-negative individuals at 2 years, when they are reinvited for screening. Colonoscopy quality may therefore require further improvement and FIT screening interval may need to be reduced after negative colonoscopy. Georg Thieme Verlag KG 2023-10-04 /pmc/articles/PMC10684335/ /pubmed/37793423 http://dx.doi.org/10.1055/a-2136-6564 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle van de Schootbrugge-Vandermeer, Hilliene J.
Kooyker, Arthur I.
Wisse, Pieter H. A.
Nagtegaal, Iris D.
Geuzinge, Hiltje A.
Toes-Zoutendijk, Esther
de Jonge, Lucie
Breekveldt, Emilie C. H.
van Vuuren, Anneke J.
van Kemenade, Folkert J.
Ramakers, Christian R. B.
Dekker, Evelien
Lansdorp-Vogelaar, Iris
Spaander, Manon C. W.
van Leerdam, Monique E.
Interval post-colonoscopy colorectal cancer following a negative colonoscopy in a fecal immunochemical test-based screening program
title Interval post-colonoscopy colorectal cancer following a negative colonoscopy in a fecal immunochemical test-based screening program
title_full Interval post-colonoscopy colorectal cancer following a negative colonoscopy in a fecal immunochemical test-based screening program
title_fullStr Interval post-colonoscopy colorectal cancer following a negative colonoscopy in a fecal immunochemical test-based screening program
title_full_unstemmed Interval post-colonoscopy colorectal cancer following a negative colonoscopy in a fecal immunochemical test-based screening program
title_short Interval post-colonoscopy colorectal cancer following a negative colonoscopy in a fecal immunochemical test-based screening program
title_sort interval post-colonoscopy colorectal cancer following a negative colonoscopy in a fecal immunochemical test-based screening program
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684335/
https://www.ncbi.nlm.nih.gov/pubmed/37793423
http://dx.doi.org/10.1055/a-2136-6564
work_keys_str_mv AT vandeschootbruggevandermeerhillienej intervalpostcolonoscopycolorectalcancerfollowinganegativecolonoscopyinafecalimmunochemicaltestbasedscreeningprogram
AT kooykerarthuri intervalpostcolonoscopycolorectalcancerfollowinganegativecolonoscopyinafecalimmunochemicaltestbasedscreeningprogram
AT wissepieterha intervalpostcolonoscopycolorectalcancerfollowinganegativecolonoscopyinafecalimmunochemicaltestbasedscreeningprogram
AT nagtegaalirisd intervalpostcolonoscopycolorectalcancerfollowinganegativecolonoscopyinafecalimmunochemicaltestbasedscreeningprogram
AT geuzingehiltjea intervalpostcolonoscopycolorectalcancerfollowinganegativecolonoscopyinafecalimmunochemicaltestbasedscreeningprogram
AT toeszoutendijkesther intervalpostcolonoscopycolorectalcancerfollowinganegativecolonoscopyinafecalimmunochemicaltestbasedscreeningprogram
AT dejongelucie intervalpostcolonoscopycolorectalcancerfollowinganegativecolonoscopyinafecalimmunochemicaltestbasedscreeningprogram
AT breekveldtemiliech intervalpostcolonoscopycolorectalcancerfollowinganegativecolonoscopyinafecalimmunochemicaltestbasedscreeningprogram
AT vanvuurenannekej intervalpostcolonoscopycolorectalcancerfollowinganegativecolonoscopyinafecalimmunochemicaltestbasedscreeningprogram
AT vankemenadefolkertj intervalpostcolonoscopycolorectalcancerfollowinganegativecolonoscopyinafecalimmunochemicaltestbasedscreeningprogram
AT ramakerschristianrb intervalpostcolonoscopycolorectalcancerfollowinganegativecolonoscopyinafecalimmunochemicaltestbasedscreeningprogram
AT dekkerevelien intervalpostcolonoscopycolorectalcancerfollowinganegativecolonoscopyinafecalimmunochemicaltestbasedscreeningprogram
AT lansdorpvogelaariris intervalpostcolonoscopycolorectalcancerfollowinganegativecolonoscopyinafecalimmunochemicaltestbasedscreeningprogram
AT spaandermanoncw intervalpostcolonoscopycolorectalcancerfollowinganegativecolonoscopyinafecalimmunochemicaltestbasedscreeningprogram
AT vanleerdammoniquee intervalpostcolonoscopycolorectalcancerfollowinganegativecolonoscopyinafecalimmunochemicaltestbasedscreeningprogram